Optimi Health Corp. - Common Shares (OPTH) closed at $3.38 on October 16, 2026, up 6.0% from the previous close, on volume of 19,947 shares (30-day average 53,721).
Data as of October 16, 2026.
Optimi Health to Present at the ThinkEquity Conference
Globe Newswire (Wed, 7-Oct 9:00 AM ET)
Optimi Health Appoints Melanie Pump to Board of Directors
Globe Newswire (Tue, 29-Sep 7:30 AM ET)
Globe Newswire (Wed, 23-Sep 9:00 AM ET)
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
Globe Newswire (Tue, 22-Sep 9:00 AM ET)
Globe Newswire (Wed, 16-Sep 8:25 AM ET)
Globe Newswire (Thu, 10-Sep 8:45 AM ET)
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Tue, 8-Sep 8:30 AM ET)
Optimi Health Establishes Discretionary Equity Facility
Globe Newswire (Fri, 14-Aug 4:55 PM ET)
Optimi Health’s Ibogaine Supply Secured as Regulatory Momentum Builds for Psychedelic Therapies
Market Chameleon (Mon, 8-Jun 4:15 AM ET)
Market Chameleon (Thu, 21-May 5:21 AM ET)
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
Optimi Health Corp. - Common Shares trades on the NASDAQ stock market under the symbol OPTH.
As of October 16, 2026, OPTH stock price climbed to $3.38 with 19,947 million shares trading.
OPTH has a beta of 3.92, meaning it tends to be more sensitive to market movements. OPTH has a correlation of 0.32 to the broad based SPY ETF.
OPTH has a market cap of $19.35 million. This is considered a Sub-Micro Cap stock.
Last quarter Optimi Health Corp. - Common Shares reported $101,275 in Revenue and -$.40 earnings per share. This fell short of revenue expectation by $-28,725 and missed earnings estimates by -$.14.
OPTH support price is $2.99 and resistance is $3.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPTH shares will trade within this expected range on the day.